Recently, researchers have suggested that mutations of the nucleophosmin1 (NPM1) gene represent the most frequent molecular alterations in AML that affect the processes of cellular differentiation and apoptosis, especially in the presence of a normal karyotype [2, 3]. The gene discussed is NPM1; the disease is acute myeloid leukemia.